Magnesium Threonate Modulation of Neuronal Intracellular Magnesium
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
Cognitive function declines with aging, leading to cognitive impairment and neurological disorders such as Alzheimer's disease, where existing treatments are inadequate in addressing synaptic loss and neuronal activity imbalances.
Innovation Solution
Administering magnesium threonate to elevate intracellular magnesium concentrations in neurons, modifying functional properties like presynaptic terminal density, mitochondrial function, and synaptic release probability, thereby improving cognitive function and treating neurological disorders.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Reliability
If existing treatments are used for cognitive impairment, then some symptomatic relief may be achieved, but synaptic loss and neuronal activity imbalances cannot be effectively addressed
Solution Approach 1:
The patent changes the chemical parameter of magnesium concentration in the extracellular environment. By administering magnesium compounds that increase extracellular magnesium levels, the invention modifies the physiological parameter of neuronal magnesium homeostasis, which in turn affects synaptic transmission and neuronal excitability. This parameter change addresses both synaptic loss and neuronal activity imbalances simultaneously.
2Reliability
If magnesium threonate is administered to elevate intracellular magnesium concentrations, then functional presynaptic terminal density and mitochondrial function increase, but the complexity of monitoring and controlling magnesium levels rises
Solution Approach 1:
The patent employs magnesium threonate as a self-regulating compound that naturally crosses the blood-brain barrier and elevates intracellular magnesium concentrations through its chemical properties. The compound itself performs the function of magnesium delivery and regulation without requiring complex external monitoring or control systems. The body's natural magnesium homeostasis mechanisms work in conjunction with the compound to maintain appropriate levels.
3Productivity
If extracellular magnesium concentration is increased to improve synaptic transmission, then cognitive function improves, but the risk of magnesium-related side effects increases
Solution Approach 1:
The patent carefully controls the parameter of extracellular magnesium concentration within a specific therapeutic range (0.6-1.4 mM, preferably 0.6-1.2 mM). This parameter optimization ensures sufficient magnesium levels to improve synaptic transmission and cognitive function while remaining below thresholds that would cause magnesium-related side effects such as muscle weakness or respiratory depression.
Solution Approach 2:
The patent achieves localized elevation of magnesium concentrations specifically in neuronal cells and synapses through the use of magnesium threonate, which preferentially accumulates in brain tissue. This localized action improves cognitive function at the target site while minimizing systemic magnesium levels and associated side effects in other organs and tissues.
Data Source
AI summary
Methods for modifying neuronal functional activity and/or treating a neurological disorder by using agents that raise neuronal intracellular concentration of magnesium are disclosed. Also provided herein are methods of determining the amenability of an individual to treatment for a neurological disorder, by measuring changes in intracellular magnesium concentration.